495 related articles for article (PubMed ID: 36737825)
21. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
[TBL] [Abstract][Full Text] [Related]
22. Bioequivalence of cefalexin in healthy Chinese subjects.
Lv X; Zhong G; Yao H; Wu J; Ye S
Int J Clin Pharmacol Ther; 2021 Nov; 59(11):725-733. PubMed ID: 34448694
[TBL] [Abstract][Full Text] [Related]
23. Bioequivalence evaluation and food effect assessment of Lisinopril/amlodipine tablets in healthy Chinese subjects under fasting and fed conditions.
Li T; Liu YP; Liu SQ; Shi P; Jiang X; Tao Y; Gao XM; Ma YP; Cao Y
BMC Pharmacol Toxicol; 2022 Jul; 23(1):45. PubMed ID: 35794660
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wu Q; Wang X; Chen Q; Zou Y; Xu X; Li T; Yu C; Zhu F; Zhang KE; Jia J; Liu Y
Drug Des Devel Ther; 2020; 14():4221-4230. PubMed ID: 33116410
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and bioequivalence evaluation of acamprosate calcium tablets in healthy Chinese volunteers.
Luo Z; Shen Y; Liang M; Miao J; Mei Y; Wang Y; Qin Y
Eur J Pharm Sci; 2015 Nov; 79():67-72. PubMed ID: 26360834
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and bioequivalence of a generic empagliflozin tablet versus a brand-named product and the food effects in healthy Chinese subjects.
Li X; Liu L; Deng Y; Li Y; Zhang P; Wang Y; Xu B
Drug Dev Ind Pharm; 2020 Sep; 46(9):1487-1494. PubMed ID: 32799565
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males.
Liu YM; Pu HH; Liu GY; Jia JY; Weng LP; Xu RJ; Li GX; Wang W; Zhang MQ; Lu C; Yu C
Clin Ther; 2010 Jul; 32(7):1396-407. PubMed ID: 20678686
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and Bioequivalence of Fudosteine in Healthy Chinese Volunteers Under Fasting and Fed Conditions: A 4-Way Replicate Crossover Study.
Zhu M; Tao Y; Pu J; Zhao H; Wan L; Zhang P; Tang C
Clin Pharmacol Drug Dev; 2023 Jan; 12(1):30-37. PubMed ID: 35794358
[TBL] [Abstract][Full Text] [Related]
29. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.
Shi S; Liu Y; Wu J; Li Z; Zhao Y; Zhong D; Zeng F
Clin Ther; 2010 Oct; 32(11):1977-86. PubMed ID: 21095492
[TBL] [Abstract][Full Text] [Related]
30. Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Zhai Y; Wu L; Zheng Y; Wu M; Huang Y; Huang Q; Shentu J; Zhao Q; Liu J
Drug Des Devel Ther; 2020; 14():3131-3142. PubMed ID: 32801649
[TBL] [Abstract][Full Text] [Related]
31. Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations.
Li C; Xu J; Zheng Y; Chen G; Wang J; Ma L; Qiao Y; Niu J; Wu M; Zhang H; Li X; Chen H; Zhu X; Liu C; Ding Y
Chem Pharm Bull (Tokyo); 2017 Jun; 65(6):524-529. PubMed ID: 28392509
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and Bioequivalence of 2 Olanzapine Orally Disintegrating Tablet Products in Healthy Chinese Subjects Under Fed and Fasting Conditions.
Fan L; Zhang L; Zheng H; Cheng J; Hu Y; Liu J; Fan H
Clin Pharmacol Drug Dev; 2020 Jul; 9(5):593-601. PubMed ID: 32413238
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and Bioequivalence of 2 Immediate-Release Tofacitinib Tablet Formulations in Chinese Healthy Volunteers Under Fasting and Fed Conditions.
Li X; Liu L; Deng Y; Li Y; Zhang P; Wang Y; Xu B; Feng J; Huang L
Clin Pharmacol Drug Dev; 2021 May; 10(5):535-541. PubMed ID: 32770665
[TBL] [Abstract][Full Text] [Related]
34. Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).
Nakade S; Komaba J; Ohno T; Kitagawa J; Furukawa K; Miyata Y
Int J Clin Pharmacol Ther; 2008 Jan; 46(1):42-7. PubMed ID: 18218297
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics, safety, and bioequivalence of apixaban tablets in healthy Chinese subjects under fasting and fed conditions.
Luo HY; Yao ZJ; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Guan YQ; Gao LC
Int J Clin Pharmacol Ther; 2023 Mar; 61(3):129-138. PubMed ID: 36458443
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and bioequivalence of two fenofibrate choline formulations in healthy subjects under fed and fasted condition
.
Park JM; Chae SI; Noh YS; Lee SJ; Shim WS; Yoon JM; Hwang SJ; Lee KT; Chung EK
Int J Clin Pharmacol Ther; 2019 Apr; 57(4):217-228. PubMed ID: 30802201
[TBL] [Abstract][Full Text] [Related]
37. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
38. Bioequivalence study of dacomitinib and Vizimpro® in healthy Chinese volunteers under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
Yang X; Li J; Zhang T; Xia Q; Zhang W; Cui Y; He W
Clin Transl Sci; 2023 Dec; 16(12):2591-2603. PubMed ID: 37786330
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and bioequivalence study of montelukast sodium oral soluble film and chewable tablet in healthy Chinese volunteers: randomized trials under fasting and fed conditions.
Zhu G; Wang L; Han S; Peng H; Tong M; Gu X; Hu H; Wang Y; Lv Z; He X
Ann Transl Med; 2023 Jan; 11(2):93. PubMed ID: 36819512
[TBL] [Abstract][Full Text] [Related]
40. A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted condition.
Cheah KY; Mah KY; Pang LH; Ng SM; Wong JW; Tan SS; Tan HZ; Yuen KH
BMC Pharmacol Toxicol; 2020 Jun; 21(1):45. PubMed ID: 32576287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
